Structures by: Rychlewska U.
Total: 99
C8H6AuCl3N2
C8H6AuCl3N2
RSC Advances (2020) 10, 72 44481-44493
a=7.6012(4)Å b=7.6086(5)Å c=9.9648(4)Å
α=111.477(5)° β=92.248(4)° γ=92.294(5)°
C8H6AuCl3N2
C8H6AuCl3N2
RSC Advances (2020) 10, 72 44481-44493
a=12.9111(4)Å b=12.1129(4)Å c=6.7647(2)Å
α=90° β=90° γ=90°
C8H6AuCl3N2
C8H6AuCl3N2
RSC Advances (2020) 10, 72 44481-44493
a=4.05530(10)Å b=11.2233(2)Å c=11.6686(3)Å
α=90° β=93.193(2)° γ=90°
C8H6AuCl3N2
C8H6AuCl3N2
RSC Advances (2020) 10, 72 44481-44493
a=7.5601(2)Å b=22.2124(5)Å c=13.5335(3)Å
α=90° β=103.107(3)° γ=90°
C8H6AuCl3N2
C8H6AuCl3N2
RSC Advances (2020) 10, 72 44481-44493
a=7.8424(4)Å b=8.1614(4)Å c=9.7794(5)Å
α=113.353(5)° β=95.989(4)° γ=104.639(4)°
Spiro-rhombimine
C54H60N4O8
Organic & biomolecular chemistry (2018) 16, 6 981-987
a=10.7257(2)Å b=11.3249(2)Å c=39.4835(5)Å
α=90° β=90° γ=90°
C22H17NO2
C22H17NO2
New Journal of Chemistry (2002)
a=9.764(2)Å b=10.273(2)Å c=17.099(3)Å
α=90.00° β=95.55(3)° γ=90.00°
C34H26N2O4
C34H26N2O4
New Journal of Chemistry (2002)
a=9.907(2)Å b=12.579(3)Å c=21.288(4)Å
α=90.00° β=98.90(3)° γ=90.00°
C34H20N2O4
C34H20N2O4
New Journal of Chemistry (2002)
a=9.855(2)Å b=12.280(2)Å c=20.602(4)Å
α=90.00° β=97.97(3)° γ=90.00°
C29H18N2O4
C29H18N2O4
New Journal of Chemistry (2002)
a=17.325(3)Å b=8.587(2)Å c=14.868(3)Å
α=90.00° β=106.36(3)° γ=90.00°
(C66H56N6O6),2(CHCl3)
(C66H56N6O6),2(CHCl3)
CrystEngComm (2018) 20, 35 5200
a=6.00320(10)Å b=30.9388(3)Å c=33.6555(2)Å
α=90° β=90° γ=90°
(C42H48N6O3),0.5(C2H6O)
(C42H48N6O3),0.5(C2H6O)
CrystEngComm (2018) 20, 35 5200
a=31.3723(17)Å b=5.5593(5)Å c=23.8849(14)Å
α=90° β=101.048(6)° γ=90°
(C42H48N6O3)
(C42H48N6O3)
CrystEngComm (2018) 20, 35 5200
a=5.7811(3)Å b=15.3719(9)Å c=23.4378(8)Å
α=102.629(4)° β=90.481(3)° γ=95.883(4)°
(C42H48N6O3),0.4(CHCl3)
(C42H48N6O3),0.4(CHCl3)
CrystEngComm (2018) 20, 35 5200
a=9.80470(10)Å b=43.1344(4)Å c=19.4077(2)Å
α=90° β=92.9350(10)° γ=90°
N-(triphenylacetyl)glycine
C22H19NO3
CrystEngComm (2019) 21, 22 3420
a=8.95680(10)Å b=10.4462(2)Å c=19.2221(3)Å
α=95.594(2)° β=91.2220(10)° γ=92.512(2)°
N-(triphenylacetyl)-L-alanine
C23H21NO3
CrystEngComm (2019) 21, 22 3420
a=13.1517(2)Å b=9.52860(10)Å c=15.2352(2)Å
α=90° β=91.7930(10)° γ=90°
N-(triphenylacetyl)-L-methionine
C25H25NO3S
CrystEngComm (2019) 21, 22 3420
a=8.9410(2)Å b=8.9410(2)Å c=54.361(2)Å
α=90° β=90° γ=90°
N-(triphenylacetyl)-L-tryptophan
C31H26N2O3
CrystEngComm (2019) 21, 22 3420
a=9.7079(12)Å b=9.4265(8)Å c=13.9926(13)Å
α=90° β=107.665(12)° γ=90°
N-(triphenylacetyl)glycylglycine
C24H22N2O4
CrystEngComm (2019) 21, 22 3420
a=13.3958(6)Å b=9.2202(3)Å c=16.7458(7)Å
α=90° β=108.447(5)° γ=90°
N-(triphenylacetyl)-L-proline methylester
C26H25NO3
CrystEngComm (2019) 21, 22 3420
a=9.1720(2)Å b=32.8820(5)Å c=13.5380(3)Å
α=90° β=90.126(2)° γ=90°
N-(triphenylacetyl)-L-valine
C25H25NO3
CrystEngComm (2019) 21, 22 3420
a=8.58960(10)Å b=9.96570(10)Å c=12.7116(2)Å
α=90° β=94.9140(10)° γ=90°
N-(triphenylacetyl)-L-proline
C25H23NO3
CrystEngComm (2019) 21, 22 3420
a=14.3139(2)Å b=15.9294(2)Å c=9.11860(10)Å
α=90° β=90° γ=90°
N-(triphenylacetyl)-L-tyrosine
C29H25NO4
CrystEngComm (2019) 21, 22 3420
a=9.1939(4)Å b=10.3126(4)Å c=24.1891(8)Å
α=90° β=90° γ=90°
N-(triphenylacetyl)-L-tert-leucine
C26H27NO3
CrystEngComm (2019) 21, 22 3420
a=8.50120(10)Å b=9.89520(10)Å c=12.8936(2)Å
α=90° β=92.2700(10)° γ=90°
N-(triphenylacetyl)glycylamino(1-cyclohexyl)ethane
C30H34N2O2
CrystEngComm (2019) 21, 22 3420
a=9.6669(3)Å b=14.8741(6)Å c=19.1839(6)Å
α=86.367(4)° β=81.808(3)° γ=71.038(3)°
N-(triphenylacetyl)glycylamino(1-tert-butyl)ethane
C28H32N2O2
CrystEngComm (2019) 21, 22 3420
a=9.8268(2)Å b=10.7524(2)Å c=12.3034(3)Å
α=104.385(2)° β=99.112(2)° γ=92.482(2)°
Trans-(2R,2'R)-bis-(2-phthalimidecyclohexyl)pyromellitdiimide
C48H40N6O8
Chemical Communications (2002) 6 582
a=18.283(4)Å b=11.023(2)Å c=11.901(2)Å
α=90.00° β=121.77(3)° γ=90.00°
C10H8Au2Cl6N2
C10H8Au2Cl6N2
Med. Chem. Commun. (2016) 7, 7 1356
a=16.2461(6)Å b=7.5152(3)Å c=14.1846(5)Å
α=90° β=97.938(3)° γ=90°
C14H19N4O3,C7H4ClO2,1.2(H2O)
C14H19N4O3,C7H4ClO2,1.2(H2O)
CrystEngComm (2003) 5, 9 48
a=7.2710(10)Å b=9.144(2)Å c=16.674(3)Å
α=86.93(3)° β=80.92(3)° γ=85.43(3)°
C14H19N4O3,C7H4O2Cl
C14H19N4O3,C7H4O2Cl
CrystEngComm (2003) 5, 9 48
a=6.545(10)Å b=28.280(6)Å c=11.633(2)Å
α=90.000(3)° β=103.37(3)° γ=90.000(3)°
Trimethoprim p-toluenesulfonate
C21H26N4O6S
CrystEngComm (2003) 5, 15 70
a=13.407(3)Å b=10.039(3)Å c=17.115(7)Å
α=90.00° β=90.60(3)° γ=90.00°
Trimethoprim sulfanilate monohydrate
C20H27N5O7S
CrystEngComm (2003) 5, 15 70
a=17.855(4)Å b=6.136(10)Å c=21.349(4)Å
α=90.00° β=109.080(3)° γ=90.00°
(2,4-diamino-5-(3',4',5'-trimethoxybenzyl)pyrimidinium) benzenesulfonate, monohydrate.
(C14H19N4O3),(C6H5SO3).H20
CrystEngComm (2003) 5, 15 70
a=17.507(2)Å b=6.323(3)Å c=21.350(2)Å
α=90.00° β=107.80(2)° γ=90.00°
2,4-diamino-5-(3',4',5'-trimethoxybenzyl)pyrimidinium 3- carboxy-4-hydroxybenzene sulfonate dihydrate
C14H19N4O3,C7H5O6S,2H2O
CrystEngComm (2003) 5, 15 70
a=11.442(2)Å b=18.769(3)Å c=12.783(3)Å
α=90.00° β=114.18(3)° γ=90.00°
C45H40N2O2
C45H40N2O2
RSC Adv. (2015)
a=8.3781(2)Å b=49.2719(9)Å c=9.1582(2)Å
α=90.00° β=115.792(2)° γ=90.00°
C46H42N2O2,CH2Cl2
C46H42N2O2,CH2Cl2
RSC Adv. (2015)
a=9.0299(2)Å b=10.5552(2)Å c=20.7459(3)Å
α=90.00° β=94.859(2)° γ=90.00°
C54H44N2O2
C54H44N2O2
RSC Adv. (2015)
a=9.44370(10)Å b=15.7060(2)Å c=13.4756(2)Å
α=90.00° β=93.4280(10)° γ=90.00°
C56H44N2O2
C56H44N2O2
RSC Adv. (2015)
a=13.2132(5)Å b=9.3519(3)Å c=17.3912(7)Å
α=90.00° β=107.395(4)° γ=90.00°
C48H46N2O2,CH2Cl2
C48H46N2O2,CH2Cl2
RSC Adv. (2015)
a=10.4884(2)Å b=19.7670(3)Å c=20.3090(3)Å
α=90.00° β=90.00° γ=90.00°
C11H17AuClN4O3,Cl,2(H2O)
C11H17AuClN4O3,Cl,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2594-2608
a=6.9310(4)Å b=11.7421(7)Å c=12.5963(8)Å
α=68.927(6)° β=79.453(5)° γ=88.221(5)°
C12H19AuClN4O3,Cl
C12H19AuClN4O3,Cl
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2594-2608
a=9.8509(2)Å b=10.7911(2)Å c=15.3736(3)Å
α=90° β=90° γ=90°
C12H19AuClN4O3,AuCl4,H2O
C12H19AuClN4O3,AuCl4,H2O
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2594-2608
a=8.35190(10)Å b=11.12680(10)Å c=24.3707(2)Å
α=90° β=90° γ=90°
C9H13AuClN4O3,AuCl4,H2O
C9H13AuClN4O3,AuCl4,H2O
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2594-2608
a=27.3091(7)Å b=8.6678(2)Å c=8.6743(2)Å
α=90° β=108.081(2)° γ=90°
C8H13.5AuClN5O7.25
C8H13.5AuClN5O7.25
Dalton transactions (Cambridge, England : 2003) (2010) 39, 38 8906-8913
a=24.5647(9)Å b=6.7463(2)Å c=17.7095(5)Å
α=90.00° β=91.215(3)° γ=90.00°
C8H11AuClN5O6
C8H11AuClN5O6
Dalton transactions (Cambridge, England : 2003) (2010) 39, 38 8906-8913
a=16.9519(19)Å b=6.6137(7)Å c=12.0312(13)Å
α=90.00° β=90.00° γ=90.00°
C9H18AuClN5O8.5
C9H18AuClN5O8.5
Dalton transactions (Cambridge, England : 2003) (2010) 39, 38 8906-8913
a=18.0271(6)Å b=7.0547(2)Å c=13.5470(4)Å
α=90.00° β=90.00° γ=90.00°
C192H240N24O12,12(O)
C192H240N24O12,12(O)
Chem.Commun. (2013) 49, 2524
a=25.7826(5)Å b=25.7826(5)Å c=25.6888(7)Å
α=90.00° β=90.00° γ=90.00°
2-oxo-2,3-dihydro-1H-imidazo[1,2-a]pyridinium bromide
C7H7N2O,Br
Acta Crystallographica Section B (2006) 62, 1 135-142
a=7.2690(10)Å b=7.709(2)Å c=8.403(2)Å
α=67.01(3)° β=68.03(3)° γ=72.00(3)°
3-[Methoxy-(2-nitro-phenyl)-methyl]-2-oxo-3H-imidazo[1,2-a]pyridinium bromide
C15H14N3O4,Br
Acta Crystallographica Section B (2006) 62, 1 135-142
a=7.3590(10)Å b=12.987(3)Å c=8.159(2)Å
α=90.00° β=105.95(3)° γ=90.00°
3-(4-Methoxy-benzyliden)-2-oxo-2,3-dihydro-1H-imidazo[1,2-a] pyridinium bromide
C15H13N2O2,Br
Acta Crystallographica Section B (2006) 62, 1 135-142
a=8.851(2)Å b=10.014(2)Å c=15.895(3)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid N,N'-dimethyldiamide
C20H20N2O6
Acta Crystallographica Section B (2002) 58, 2 265-271
a=10.282(2)Å b=18.024(4)Å c=5.1360(10)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid diamide
(C18H16N2O6),(C4H8O2)
Acta Crystallographica Section B (2002) 58, 2 265-271
a=5.2530(10)Å b=26.748(5)Å c=15.621(3)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid diamide
(C18H16N2O6),(C5H5N)
Acta Crystallographica Section B (2002) 58, 2 265-271
a=27.898(6)Å b=5.1450(10)Å c=15.648(3)Å
α=90.00° β=93.49(3)° γ=90.00°
Dimethyl (R,R)-(-)-O,O'-Dibenzoyltartrate
C20H18O8
Acta Crystallographica Section B (2002) 58, 2 265-271
a=9.4620(10)Å b=17.653(3)Å c=5.6620(10)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid mono(N-methylamide) monomethylester
C20H19NO7
Acta Crystallographica Section B (2002) 58, 2 265-271
a=9.898(2)Å b=17.756(4)Å c=5.2640(10)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(+)-Tartaric acid monoamide
C4H7NO5
Acta Crystallographica Section B (2000) 56, 5 833-848
a=5.9556(5)Å b=8.0972(5)Å c=11.8960(8)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(+)-Tartaric acid N,N'-dimethyldiamide monohydrate
C6H14N2O5
Acta Crystallographica Section B (2000) 56, 5 833-848
a=5.0940(10)Å b=11.243(2)Å c=16.295(4)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(+)-Tartaric acid N-methyldiamide
C5H10N2O4
Acta Crystallographica Section B (2000) 56, 5 833-848
a=10.5940(10)Å b=10.5940(10)Å c=13.771(3)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid mono(N-methylamide)
(C19H17NO7),(H2O)
Acta Crystallographica Section B (2001) 57, 3 415-427
a=8.7977(8)Å b=10.7520(10)Å c=20.177(2)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid mono(N,N-dimethylamide)
C20H19NO7
Acta Crystallographica Section B (2001) 57, 3 415-427
a=8.6699(6)Å b=12.0105(7)Å c=18.6570(10)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid N,N,N'-trimethyldiamide
C21H22N2O6
Acta Crystallographica Section B (2001) 57, 3 415-427
a=8.9010(10)Å b=11.2720(10)Å c=10.4140(10)Å
α=90.00° β=99.470(10)° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid N,N-dimethyldiamide
C20H20N2O6
Acta Crystallographica Section B (2001) 57, 3 415-427
a=8.9153(6)Å b=11.7580(10)Å c=17.9760(10)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid monoamide monomethylester
C19H17NO7
Acta Crystallographica Section B (2001) 57, 3 415-427
a=7.1930(10)Å b=14.515(2)Å c=18.083(2)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid mono(N,N-dimethylamide) monomethylester
C21H21NO7
Acta Crystallographica Section B (2001) 57, 3 415-427
a=8.1270(10)Å b=14.109(2)Å c=8.7330(10)Å
α=90.00° β=97.970(10)° γ=90.00°
N,N-Dimethyl(2R,3S)-2,3-dibenzoyloxy-3-cyanopropanamide
C20H18N2O5
Acta Crystallographica Section B (2001) 57, 3 415-427
a=7.749(2)Å b=14.144(4)Å c=9.063(2)Å
α=90.00° β=110.34(2)° γ=90.00°
(R,R)-(-)-O,O'-Dibenzoyltartaric acid monoamide
(C18H15N1O7),0.15(H2O)
Acta Crystallographica Section B (2001) 57, 3 415-427
a=7.3930(4)Å b=19.9500(10)Å c=12.1630(6)Å
α=90.00° β=97.770(4)° γ=90.00°
C43H30N2O8
C43H30N2O8
Acta Crystallographica Section B (2009) 65, 1 86-95
a=9.2897(7)Å b=10.0849(7)Å c=11.0897(8)Å
α=103.203(6)° β=111.486(7)° γ=107.147(6)°
C41H26N2O8
C41H26N2O8
Acta Crystallographica Section B (2009) 65, 1 86-95
a=16.9672(9)Å b=8.0833(3)Å c=25.0204(5)Å
α=90.00° β=116.312(3)° γ=90.00°
C15H21N2S,Cl
C15H21N2S,Cl
Acta Crystallographica Section B (2010) 66, 6 678-686
a=9.05380(10)Å b=9.05380(10)Å c=32.4921(4)Å
α=90.00° β=90.00° γ=120.00°
Bis(23-carboxy-24-nor-5beta-cholan-3alpha-yl)terephtalate
C56H82O8,2(C5H5N)
Acta Crystallographica Section B (2008) 64, 3 383-392
a=12.8559(6)Å b=13.5462(7)Å c=17.4215(9)Å
α=75.390(4)° β=83.254(4)° γ=82.771(4)°
C8H8N2O4
C8H8N2O4
Acta Crystallographica Section B (2008) 64, 4 497-503
a=8.6112(3)Å b=9.8185(3)Å c=11.7898(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(23-methoxycarbonyl-24-nor-5beta-cholan -3alpha-yl)terephtalate
C58H86O8
Acta Crystallographica Section B (2008) 64, 3 383-392
a=31.731(6)Å b=7.727(2)Å c=11.017(2)Å
α=90.00° β=106.28(3)° γ=90.00°
Bis(23-carboxy-24-nor-5beta-cholan-3alpha-yl)terephtalate
C56H82O8,2(C5H5N)
Acta Crystallographica Section B (2008) 64, 3 383-392
a=6.8044(5)Å b=12.8870(9)Å c=17.0661(11)Å
α=94.431(6)° β=97.935(6)° γ=97.341(5)°
C4H4N2O2
C4H4N2O2
Acta Crystallographica Section B (2008) 64, 4 497-503
a=7.2155(15)Å b=6.2725(12)Å c=10.828(2)Å
α=90.00° β=90.00° γ=90.00°
C8H8N2O4
C8H8N2O4
Acta Crystallographica Section B (2008) 64, 4 497-503
a=12.4510(4)Å b=8.5089(3)Å c=18.0764(5)Å
α=90.00° β=90.00° γ=90.00°
Bis(23-methoxycarbonyl-24-nor-5beta-cholan-3alpha-yl) piperazine 1,4-dicarboxylate
C56H90N2O8,0.5(CH3OH)
Acta Crystallographica Section B (2008) 64, 3 383-392
a=7.7755(9)Å b=9.8697(11)Å c=17.754(2)Å
α=103.040(13)° β=101.086(10)° γ=90.463(9)°
C44H30N2O8
C44H30N2O8
Acta Crystallographica Section B (2009) 65, 1 86-95
a=11.873(2)Å b=11.873(2)Å c=43.046(9)Å
α=90.00° β=90.00° γ=120.00°
C44H32O6N4,C2H6OS,H2O
C44H32O6N4,C2H6OS,H2O
Acta Crystallographica Section B (2009) 65, 1 86-95
a=22.374(4)Å b=9.319(2)Å c=20.515(4)Å
α=90.00° β=110.14(3)° γ=90.00°
Nickel-ferron complex
C18H20I2N2Ni2O14S2,4H2O
Acta Crystallographica Section E (2003) 59, 1 m46-m49
a=22.053(4)Å b=10.009(2)Å c=13.241(3)Å
α=90° β=100.760(3)° γ=90°
Magnesium ferron pentahydrate
C18H20I2Mg2N2O14S2,4H2O
Acta Crystallographica Section E (2004) 60, 2 m137-m139
a=22.584(5)Å b=10.026(2)Å c=13.401(3)Å
α=90° β=102.26(3)° γ=90°
Calcium ferron trihydrate
C18H14CaI2N2O10S2,H2O
Acta Crystallographica Section E (2003) 59, 12 m1160-m1163
a=20.326(4)Å b=6.9580(10)Å c=19.219(4)Å
α=90° β=117.19(3)° γ=90°
C20H24O5
C20H24O5
Acta Crystallographica Section C (1992) 48, 8 1543-1547
a=7.8420(10)Å b=13.840(2)Å c=8.5360(10)Å
α=90.0° β=100.040(10)° γ=90.0°
C20H26O4
C20H26O4
Acta Crystallographica Section C (1992) 48, 8 1543-1547
a=8.0350(10)Å b=7.2080(10)Å c=15.887(3)Å
α=90.0° β=90.920(10)° γ=90.0°
(R,R)-Tartaric Acid Mono (N-Methylamide) Monohydrate
C5H9N1O5,H2O
Acta Crystallographica Section B (1999) 55, 4 617-625
a=7.3010(10)Å b=7.658(2)Å c=13.855(3)Å
α=90.00° β=90.00° γ=90.00°
C22H24N2O6
C22H24N2O6
Acta Crystallographica Section C (1992) 48, 5 965-969
a=9.5780(10)Å b=13.6920(10)Å c=8.5080(10)Å
α=90° β=102.783(9)° γ=90°
C8H16N2O4
C8H16N2O4
Acta Crystallographica Section C (1992) 48, 5 965-969
a=9.4370(10)Å b=9.4370(10)Å c=10.6900(10)Å
α=90.0° β=90.0° γ=120.0°
Pyrimethamine m-chlorobenzoate
C12H14ClN4,C7H4ClO2
Acta Crystallographica Section E (2006) 62, 9 o3704-o3706
a=9.139(2)Å b=10.337(2)Å c=11.121(2)Å
α=65.90(3)° β=82.80(3)° γ=76.45(3)°
2-amino-4,6-dimethylpyrimidinium salicylate
C6H10N3,C7H5O3
Acta Crystallographica Section C (2006) 62, 10 o605-o607
a=11.039(2)Å b=13.995(3)Å c=17.371(3)Å
α=90° β=99.04(3)° γ=90°
Pyrimethaminium(2+) nitrate
C12H15ClN42,2NO3
Acta Crystallographica Section C (2005) 61, 10 o586-o588
a=32.700(7)Å b=12.926(3)Å c=16.065(3)Å
α=90° β=104.73(3)° γ=90°
Poly[[μ-aqua-diaqua(μ~5~-propane-1,3- diyldinitrilotetraacetato)dilithium(I)cobalt(II)] dihydrate]
C11H20CoLi2N2O11,2H2O
Acta Crystallographica Section C (2008) 64, 6 m217-m220
a=7.8767(4)Å b=12.7381(6)Å c=9.3440(4)Å
α=90.00° β=90.756(4)° γ=90.00°
(<i>S</i>,<i>S</i>)-(Ethane-1,2-diyl)bis[(2-methylphenyl)phenylphosphane]
C28H28P2
Acta Crystallographica Section C (2014) 70, 12 1174-1177
a=5.97250(10)Å b=17.0935(2)Å c=22.8179(3)Å
α=90.00° β=90.00° γ=90.00°
2-amino-4,6-dimethylpyrimidinium hydrogensulfate
C6H10N3,H1O4S1
Acta Crystallographica Section C (2005) 61, 2 o95-o97
a=7.0250(10)Å b=6.7240(10)Å c=20.200(4)Å
α=90.00° β=90.27(3)° γ=90.00°
Glycyl-methionine sulfoxide hydrogen tetrachloroaurate
C7H15N2O4S,AuCl4
Acta Crystallographica Section C (2010) 66, 2 m51-m54
a=7.6250(5)Å b=10.2576(4)Å c=10.7160(7)Å
α=95.281(4)° β=107.222(6)° γ=92.001(4)°
Poly[bis(dimethylammonium) [hexa-μ~2~-formato-κ^12^<i>O</i>:<i>O</i>-aluminium(III)sodium(I)]]
2C2H8N,C6H6AlNaO122
Acta Crystallographica Section C (2009) 65, 2 m75-m77
a=8.2510(10)Å b=8.2510(10)Å c=22.949(3)Å
α=90° β=90° γ=120°
Poly[[tetraaquabis(μ~2~-hydroxyacetato- κ^4^<i>O</i>^1^,<i>O</i>^2^:<i>O</i>^1^,<i>O</i>^1^)-μ~2~-sulfato- κ^2^<i>O</i>:<i>O</i>'-dicadmium(II)] monohydrate]
C4H14Cd2O14S,H2O
Acta Crystallographica Section E (2009) 65, 6 m648-m649
a=13.5750(3)Å b=8.57770(10)Å c=13.7734(3)Å
α=90.00° β=107.528(2)° γ=90.00°
C16H14O6
C16H14O6
Journal of Organic Chemistry (2009) 74, 4573-4583
a=5.4881(3)Å b=8.1373(4)Å c=15.7785(7)Å
α=90.00° β=91.134(4)° γ=90.00°
C24H18O6
C24H18O6
Journal of Organic Chemistry (2009) 74, 4573-4583
a=5.8352(2)Å b=7.9311(3)Å c=20.5792(8)Å
α=100.020(3)° β=92.974(3)° γ=92.513(3)°
C40H40N4O2,2(C6H6)
C40H40N4O2,2(C6H6)
Journal of Organic Chemistry (2005) 70, 10147-10150
a=8.817(2)Å b=14.894(3)Å c=32.741(7)Å
α=90.00° β=90.00° γ=90.00°
C18H12N2O4
C18H12N2O4
Acta Crystallographica Section B (2008) 64, 4 497-503
a=5.7840(14)Å b=7.3241(18)Å c=10.229(3)Å
α=106.26(2)° β=105.30(2)° γ=96.55(2)°